These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 24096997)
1. Glucose transporter 3 and 1 may facilitate high uptake of 18F-FDG in gastric schwannoma. Shimada Y; Sawada S; Hojo S; Okumura T; Nagata T; Nomoto K; Tsukada K Clin Nucl Med; 2013 Nov; 38(11):e417-20. PubMed ID: 24096997 [TBL] [Abstract][Full Text] [Related]
2. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma. Shim HK; Lee WW; Park SY; Kim H; Kim SE Oncol Res; 2009; 17(7):331-7. PubMed ID: 19408578 [TBL] [Abstract][Full Text] [Related]
3. Clinical, Morphologic, and Pathologic Features Associated With Increased FDG Uptake in Schwannoma. Miyake KK; Nakamoto Y; Kataoka TR; Ueshima C; Higashi T; Terashima T; Nakatani K; Saga T; Minami S; Togashi K AJR Am J Roentgenol; 2016 Dec; 207(6):1288-1296. PubMed ID: 27657364 [TBL] [Abstract][Full Text] [Related]
4. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma. Park SG; Lee JH; Lee WA; Han KM Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702 [TBL] [Abstract][Full Text] [Related]
5. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression. Alakus H; Batur M; Schmidt M; Drebber U; Baldus SE; Vallböhmer D; Prenzel KL; Metzger R; Bollschweiler E; Hölscher AH; Mönig SP Nucl Med Commun; 2010 Jun; 31(6):532-8. PubMed ID: 20220543 [TBL] [Abstract][Full Text] [Related]
6. Correlation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesions. Wang ZG; Yu MM; Han Y; Wu FY; Yang GJ; Li DC; Liu SM Medicine (Baltimore); 2016 Nov; 95(48):e5462. PubMed ID: 27902598 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression. Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670 [TBL] [Abstract][Full Text] [Related]
8. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours. Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658 [TBL] [Abstract][Full Text] [Related]
9. Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients? Choi WH; Yoo IeR; O JH; Kim TJ; Lee KY; Kim YK Technol Health Care; 2015; 23 Suppl 2():S311-8. PubMed ID: 26410497 [TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro. Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Kitamura K; Ikai I; Uemoto S Int J Oncol; 2009 May; 34(5):1303-12. PubMed ID: 19360342 [TBL] [Abstract][Full Text] [Related]
11. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II. Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473 [TBL] [Abstract][Full Text] [Related]
12. Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases. Ohno T; Ogata K; Kogure N; Ando H; Aihara R; Mochiki E; Zai H; Sano A; Kato T; Sakurai S; Oyama T; Asao T; Kuwano H Surg Today; 2011 Aug; 41(8):1133-7. PubMed ID: 21773906 [TBL] [Abstract][Full Text] [Related]
13. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer. Chung JH; Lee WW; Park SY; Choe G; Sung SW; Chung JK; Lee MC; Kim SE Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874 [TBL] [Abstract][Full Text] [Related]
14. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival. Schlößer HA; Drebber U; Urbanski A; Haase S; Baltin C; Berlth F; Neiß S; von Bergwelt-Baildon M; Fetzner UK; Warnecke-Eberz U; Bollschweiler E; Hölscher AH; Mönig SP; Alakus H Gastric Cancer; 2017 Jan; 20(1):83-91. PubMed ID: 26643879 [TBL] [Abstract][Full Text] [Related]
15. No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma. Charnley N; Airley R; Du Plessis D; West C; Brock C; Barnett C; Matthews J; Symonds K; Bottomly M; Swindell R; Price P Oncol Rep; 2008 Sep; 20(3):537-42. PubMed ID: 18695903 [TBL] [Abstract][Full Text] [Related]
16. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. Yen TC; See LC; Lai CH; Yah-Huei CW; Ng KK; Ma SY; Lin WJ; Chen JT; Chen WJ; Lai CR; Hsueh S J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665 [TBL] [Abstract][Full Text] [Related]
17. Correlation of Glut-1 glucose transporter expression with. Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940 [TBL] [Abstract][Full Text] [Related]